Skip to content

MODIFICATION TO:STRAUMANN GUIDED INSTRUMENTS SLActive Roxolid TL (REF 033.431G)Recalls & reported problems

Institut Straumann AG · Standard Implant D 3.3mm RN, SLActive® 8mm, Roxolid® guided · Class 2 · Implant

All models of MODIFICATION TO:STRAUMANN GUIDED INSTRUMENTS (20)

Data updated Oct 16, 2026 from official FDA records · Editorial policy

Adverse event reports
1
Deaths reported
0
Injuries reported
1
Recalls naming it
0

Summary

The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 07630031715555), received between May 27, 2021 and May 27, 2021 — classified as 1 injury.

The most frequently reported specific device problem is “Failure to Osseointegrate” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.

Most reported problems

Device problems

  • Failure to Osseointegrate1

Patient problems

  • Fibrosis1
  • Hemorrhage/Blood Loss/Bleeding1
  • Pain1

Recent adverse event reports

The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.

  • InjuryMay 27, 2021Failure to Osseointegrate; Failure to Osseointegrate

    THE CLINICIAN REPORTS THE IMPLANT WAS INSERTED (B)(6) 2021 IN FDI 23. ON (B)(6) 2021, NON-OSSEOINTEGRATION WAS VERIFIED. PATIENT PRESENTED WITH INADEQUATE BONE QUALITY/QUANTITY. THE DEVICE WAS FORWARDED TO THE MANUFACTURER. AT THE EVENT THE PATIENT EXPERIENCED: PAIN, MOBILITY AND BLEEDING. NO FURTHER PATIENT COMPLICATIONS WERE REPORTED.

    Patient problems: Fibrosis; Hemorrhage/Blood Loss/Bleeding; Pain

    MAUDE report 11895723 ↗

Other IMPLANT, ENDOSSEOUS, ROOT-FORM devices

All IMPLANT, ENDOSSEOUS, ROOT-FORM devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page